Okay, let's tackle this question about adverse effects of combined oral contraceptives. First, I need to recall what COCs are. They contain estrogen and progestin. Common adverse effects include things like nausea, breast tenderness, and maybe more serious ones like increased risk of blood clots. The question is asking which of the options is an adverse effect.

The core concept here is understanding the side effects of COCs. They work by inhibiting ovulation and altering the endometrium. But their use is linked to various adverse effects, especially cardiovascular and thromboembolic events. Also, they can cause changes in lipid profiles and liver function.

The correct answer is probably something like increased risk of thromboembolism. Let me think. Other options might include things like weight loss, decreased risk of endometrial cancer, or maybe something like galactorrhea. Wait, galactorrhea is more associated with progestin-only pills or drugs that increase prolactin. So if an option says galactorrhea, that's incorrect.

For the incorrect options: if one of them is weight gain, that's a common misconception but not a well-established adverse effect. Another might be decreased risk of ovarian cancer, which is actually a protective effect, so that's a wrong answer. Another distractor could be hypotension, but COCs are more likely to cause hypertension.

The clinical pearl here is that COCs increase the risk of venous thromboembolism, especially in smokers over 35. Also, they can increase the risk of myocardial infarction. So the high-yield fact is the thromboembolic risk.

**Core Concept:** Combined oral contraceptives (COCs) contain estrogen and progestin, which modulate ovarian function and endometrial receptivity. Their adverse effects include thromboembolic risks due to estrogen-induced hypercoagulability and metabolic changes, such as increased low-density lipoprotein (LDL) and decreased high-density lipoprotein (HDL).

**Why the Correct Answer is Right:** The correct adverse effect is **thromboembolism**, primarily due to estrogen's role in enhancing clotting factors (II, VII, IX, X) and reducing anticoagulant proteins (protein S, antithrombin III). This increases the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly in smokers or those with genetic thrombophilia. COCs also elevate blood pressure and may worsen hypertension.

**Why Each Wrong Option is Incorrect:**
**Option A:** *Weight loss* is incorrect; COCs often cause fluid retention or appetite changes but are not consistently linked to weight loss.
**Option B:** *Galactorrhea* is incorrect; this is more associated with progestin-only pills or dopamine antagonists, not COCs.
**Option C:** *Decreased risk of endometrial cancer* is incorrect; this is a **protective benefit**, not an adverse effect, due to reduced endometrial proliferation.
**Option D:** *Hypotension* is incorrect; COCs may cause **hypertension**, especially with prolonged use.

**Clinical Pearl / High-Yield Fact:** COCs increase the risk of **venous thromboembolism (VTE)** 3- to 4-fold, with

✓ Correct Answer: A. Cerebral stroke